TY - JOUR
T1 - Comparative efficacy of 10 antimicrobial agents in experimental infections with bacteroides fragllis
AU - Joiner, Keith
AU - Lowe, Bruce
AU - Dzink, Jody
AU - Bartlett, John G.
N1 - Funding Information:
Received for publication April 20, 1981, and in revised form December 16, 1981. This study was supported by grants from the Upjohn Company, Eli Lilly and Company, Pfizer, and the Schering Corporation. Please address requests for reprints to Dr. John G. Bartlett at his present address: Blalock 1111, The Johns Hopkins Hospital, Baltimore, Maryland 21205.
PY - 1982/4
Y1 - 1982/4
N2 - The comparative efficacy of 10 antimicrobial agents against 15 strains of Bacteroides was examined in vivo using an experimental model of subcutaneous abscesses in mice. Results were evaluated by bacterial counts per lesion with the antimicrobial agents administered beginning 1 hr after challenge. Six drugs reduced counts (mean ± SEM log decrease) significantly compared with values in untreated control animals: metronidazole, 6.7 ± 0.6; clindamycin, 5.0 ± 0.6; moxalactam, 3.8 ± 0.5; cefoxitin, 3.5 ± 0.5; chloramphenicol, 1.6 ± 0.5; and carbenicillin, 1.0 ± 0.3. Antimicrobial agents that had no significant effect compared with values in untreated control animals were cephalothin, cefoperazone, ceforanide, and rosaramicin. Evaluation of several parameters based on in vitro activity and pharmacokinetic properties at the infected site indicated that the time during which the level of antimicrobial agent exceeded the minimal inhibitory concentration correlated best with in vivo antibacterial activity. A delay in the time that treatment was initiated resulted in a marked reduction in in vivo activity.
AB - The comparative efficacy of 10 antimicrobial agents against 15 strains of Bacteroides was examined in vivo using an experimental model of subcutaneous abscesses in mice. Results were evaluated by bacterial counts per lesion with the antimicrobial agents administered beginning 1 hr after challenge. Six drugs reduced counts (mean ± SEM log decrease) significantly compared with values in untreated control animals: metronidazole, 6.7 ± 0.6; clindamycin, 5.0 ± 0.6; moxalactam, 3.8 ± 0.5; cefoxitin, 3.5 ± 0.5; chloramphenicol, 1.6 ± 0.5; and carbenicillin, 1.0 ± 0.3. Antimicrobial agents that had no significant effect compared with values in untreated control animals were cephalothin, cefoperazone, ceforanide, and rosaramicin. Evaluation of several parameters based on in vitro activity and pharmacokinetic properties at the infected site indicated that the time during which the level of antimicrobial agent exceeded the minimal inhibitory concentration correlated best with in vivo antibacterial activity. A delay in the time that treatment was initiated resulted in a marked reduction in in vivo activity.
UR - http://www.scopus.com/inward/record.url?scp=0020049279&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020049279&partnerID=8YFLogxK
U2 - 10.1093/infdis/145.4.561
DO - 10.1093/infdis/145.4.561
M3 - Article
C2 - 7069236
AN - SCOPUS:0020049279
SN - 0022-1899
VL - 145
SP - 561
EP - 568
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 4
ER -